Literature DB >> 19033443

MSL2 promotes Mdm2-independent cytoplasmic localization of p53.

Jan-Philipp Kruse1, Wei Gu.   

Abstract

Although it was originally thought of as a passive way to block the nuclear function of p53, accumulating evidence suggests that cytoplasmic localization of p53 plays an active role in p53-mediated functions such as apoptosis and autophagy. Previous studies by us and others demonstrated that Mdm2-mediated p53 ubiquitination induces both degradation and cytoplasmic localization. Here we describe MSL2, a novel E3 ligase for p53 that promotes ubiquitin-dependent cytoplasmic p53 localization. Unlike Mdm2 or most other p53 E3 ligases, MSL2-mediated p53 ubiquitination does not affect the stability of p53. Moreover, the MSL2-mediated effect on p53 is Mdm2-independent. Thus, our study identifies an important ubiquitin-ligase for modulating p53 subcellular localization.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19033443      PMCID: PMC2631942          DOI: 10.1074/jbc.M805658200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  67 in total

Review 1.  Transcription-independent pro-apoptotic functions of p53.

Authors:  Ute M Moll; Sonja Wolff; Daniel Speidel; Wolfgang Deppert
Journal:  Curr Opin Cell Biol       Date:  2005-10-13       Impact factor: 8.382

2.  Dissection of transcriptional and non-transcriptional p53 activities in the response to genotoxic stress.

Authors:  D Speidel; H Helmbold; W Deppert
Journal:  Oncogene       Date:  2006-02-09       Impact factor: 9.867

3.  Functional analysis of the roles of posttranslational modifications at the p53 C terminus in regulating p53 stability and activity.

Authors:  Lijin Feng; Tongxiang Lin; Hiroaki Uranishi; Wei Gu; Yang Xu
Journal:  Mol Cell Biol       Date:  2005-07       Impact factor: 4.272

4.  The p53QS transactivation-deficient mutant shows stress-specific apoptotic activity and induces embryonic lethality.

Authors:  Thomas M Johnson; Ester M Hammond; Amato Giaccia; Laura D Attardi
Journal:  Nat Genet       Date:  2005-01-16       Impact factor: 38.330

Review 5.  The transcriptional targets of p53 in apoptosis control.

Authors:  Jian Yu; Lin Zhang
Journal:  Biochem Biophys Res Commun       Date:  2005-06-10       Impact factor: 3.575

Review 6.  p53 ubiquitination: Mdm2 and beyond.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Mol Cell       Date:  2006-02-03       Impact factor: 17.970

7.  WT p53, but not tumor-derived mutants, bind to Bcl2 via the DNA binding domain and induce mitochondrial permeabilization.

Authors:  York Tomita; Natasha Marchenko; Susan Erster; Alice Nemajerova; Alexander Dehner; Christian Klein; Hongguang Pan; Horst Kessler; Petr Pancoska; Ute M Moll
Journal:  J Biol Chem       Date:  2006-01-26       Impact factor: 5.157

8.  A human protein complex homologous to the Drosophila MSL complex is responsible for the majority of histone H4 acetylation at lysine 16.

Authors:  Edwin R Smith; Christelle Cayrou; Rong Huang; William S Lane; Jacques Côté; John C Lucchesi
Journal:  Mol Cell Biol       Date:  2005-11       Impact factor: 4.272

9.  ARF-BP1/Mule is a critical mediator of the ARF tumor suppressor.

Authors:  Delin Chen; Ning Kon; Muyang Li; Wenzhu Zhang; Jun Qin; Wei Gu
Journal:  Cell       Date:  2005-07-01       Impact factor: 41.582

Review 10.  p53 moves to mitochondria: a turn on the path to apoptosis.

Authors:  Maureen E Murphy; J I-Ju Leu; Donna L George
Journal:  Cell Cycle       Date:  2004-07-04       Impact factor: 4.534

View more
  40 in total

1.  The cancer-associated K351N mutation affects the ubiquitination and the translocation to mitochondria of p53 protein.

Authors:  Michela Muscolini; Elisa Montagni; Vanessa Palermo; Silvia Di Agostino; Wei Gu; Salma Abdelmoula-Souissi; Cristina Mazzoni; Giovanni Blandino; Loretta Tuosto
Journal:  J Biol Chem       Date:  2011-09-27       Impact factor: 5.157

Review 2.  Making sense of ubiquitin ligases that regulate p53.

Authors:  Abhinav K Jain; Michelle Craig Barton
Journal:  Cancer Biol Ther       Date:  2010-10-01       Impact factor: 4.742

3.  Extensive post-translational modification of active and inactivated forms of endogenous p53.

Authors:  Caroline J DeHart; Jasdave S Chahal; S J Flint; David H Perlman
Journal:  Mol Cell Proteomics       Date:  2013-09-20       Impact factor: 5.911

4.  Control of p53 multimerization by Ubc13 is JNK-regulated.

Authors:  Ivan Topisirovic; Gustavo J Gutierrez; Meifan Chen; Ettore Appella; Katherine L B Borden; Ze'ev A Ronai
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-27       Impact factor: 11.205

Review 5.  The impact of acetylation and deacetylation on the p53 pathway.

Authors:  Christopher L Brooks; Wei Gu
Journal:  Protein Cell       Date:  2011-07-12       Impact factor: 14.870

Review 6.  Dosage Compensation in Drosophila-a Model for the Coordinate Regulation of Transcription.

Authors:  Mitzi I Kuroda; Andres Hilfiker; John C Lucchesi
Journal:  Genetics       Date:  2016-10       Impact factor: 4.562

7.  The RING finger protein MSL2 in the MOF complex is an E3 ubiquitin ligase for H2B K34 and is involved in crosstalk with H3 K4 and K79 methylation.

Authors:  Lipeng Wu; Barry M Zee; Yanming Wang; Benjamin A Garcia; Yali Dou
Journal:  Mol Cell       Date:  2011-07-08       Impact factor: 17.970

8.  It Takes 15 to Tango: Making Sense of the Many Ubiquitin Ligases of p53.

Authors:  Ian M Love; Steven R Grossman
Journal:  Genes Cancer       Date:  2012-03

Review 9.  Regulation and function of histone acetyltransferase MOF.

Authors:  Yang Yang; Xiaofei Han; Jingyun Guan; Xiangzhi Li
Journal:  Front Med       Date:  2014-01-23       Impact factor: 4.592

Review 10.  The ubiquitin proteasome system in neuropathology.

Authors:  Norman L Lehman
Journal:  Acta Neuropathol       Date:  2009-07-14       Impact factor: 17.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.